3 Biotech, Journal Year: 2024, Volume and Issue: 15(1)
Published: Dec. 20, 2024
Language: Английский
3 Biotech, Journal Year: 2024, Volume and Issue: 15(1)
Published: Dec. 20, 2024
Language: Английский
Chemical Papers, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 6, 2025
Language: Английский
Citations
0DNA repair, Journal Year: 2025, Volume and Issue: 149, P. 103827 - 103827
Published: March 16, 2025
Oxidative DNA damage, resulting from endogenous cellular processes and external sources plays a significant role in mutagenesis, cancer progression, the pathogenesis of neurological disorders. Base Excision Repair (BER) is involved repair base modifications such as oxidations or alkylations well single strand breaks. The glycosylase OGG1, initiates BER pathway by recognition excision 8oxoG, most common oxidative lesion, both nuclear mitochondrial DNA. Beyond repair, OGG1 modulates transcription, particularly pro-inflammatory genes, linking damage to broader biological like inflammation aging. In therapy, inhibition has emerged promising strategy enhance treatment efficacy. Targeting sensitizes cells chemotherapies, radiotherapies, PARP inhibitors, presenting opportunities overcome therapy resistance. Additionally, activators hold potential mitigating associated with aging This review presents development several inhibitors how they have contributed advance our knowledge fundamental functions OGG1. We also discuss new provide for clinical applications treating cancer, Finally, we highlight challenges targeting regarding off-target effects recently reported some can these limitations.
Language: Английский
Citations
0Cellular Signalling, Journal Year: 2025, Volume and Issue: unknown, P. 111743 - 111743
Published: March 1, 2025
Language: Английский
Citations
0Discover Nano, Journal Year: 2025, Volume and Issue: 20(1)
Published: April 24, 2025
Cancer treatments often exploit oxidative stress to selectively kill tumour cells by disrupting their lipid peroxidation membranes and inhibiting antioxidant enzymes. However, plays a dual role in cancer progression, acting as both promoter suppressor. Balancing through therapy remains challenge, excessive activity may compromise the efficacy of chemotherapy radiotherapy. This review explores antioxidants mitigating while maintaining treatment efficacy. It highlights recent advancements nanotechnology-based targeted delivery optimize therapeutic outcomes. A comprehensive literature was conducted using reputable databases, including PubMed, Scopus, Web Science, ScienceDirect. The search focused on publications from past five years (2020-2025), supplemented relevant studies earlier years. Keywords such "antioxidants," "lipid peroxidation," "nanotechnology therapy," "oxidative stress" were utilized. Relevant articles critically analysed, graphical illustrations created. Emerging evidence suggests that nanoparticles, liposomes, polymeric metal-organic frameworks, others, can effectively encapsulate control release minimizing systemic toxicity. Stimuli-responsive carriers with tumour-specific targeting mechanisms further enhance delivery. Studies indicate these strategies help preserve normal cells, mitigate stress-related damage, improve challenges bioavailability, stability, potential interactions standard therapies remain. Integrating nanotechnology antioxidant-based interventions presents promising approach for optimizing therapy. Future research should focus refining modulation strategies, assessing profiles during treatment, employing biomarkers determine optimal dosing. balanced use adverse effects.
Language: Английский
Citations
0Colloids and Surfaces B Biointerfaces, Journal Year: 2025, Volume and Issue: 253, P. 114732 - 114732
Published: April 24, 2025
Language: Английский
Citations
03 Biotech, Journal Year: 2024, Volume and Issue: 15(1)
Published: Dec. 20, 2024
Language: Английский
Citations
0